|Day Low/High||140.58 / 144.43|
|52 Wk Low/High||109.16 / 157.00|
Let's go over what allows us to get to highs for the year.
Federal Reserve Chair Janet Yellen should say the Fed can't raise interest rates right now when she speaks in Philadelphia on Monday, according to Jim Cramer.
This is because they would buy more of the winning stocks lower.
Do the homework and you'll find great stocks.
Jim Cramer says he likes Johnson & Johnson's purchase of privately-held hair care products maker Vogue International.
U.S. stocks opened slightly lower on Thursday, as investors parsed commentary from European Central Bank President Mario Draghi, following its June policy meeting.
Peter Lynch and other market legends would love these names.
Many familiar names, but are any worth buying?
Coming off a brutal first quarter, Bill Ackman's hedge fund announced the loss of a key strategist.
The expected legal deluge will be manageable thanks to JNJ's massive size and financial strength.
There is an overall flow of funds out of the stock market after a weak jobs report.
Investors are going to rotate back into safety stocks if the April jobs number disappoints on Friday, says TheStreet's Jim Cramer.
It has pivoted from desktop dinosaur to mobile monster in no time flat.
Jim Cramer believes the pharmaceutical sector has come full circle and some of the best stocks in the group are ready to move higher.
Why sell companies that will benefit from a weaker dollar?
U.S. stocks remained mixed through the afternoon on Tuesday.
Everything about the CEO's move to Valeant stinks.
All this time I've been bullish because fiscal flows told me to be.
Look for JNJ to trade higher, but a close below $107 will turn the picture to bearish from bullish.
Jim Cramer says it you are going to own a drug stock, invest in Allergan or Johnson & Johnson.
Jim Cramer says J&J's latest quarterly report highlights strong sales of prescription drugs globally.
The rally continues. U.S. stocks moved higher on Tuesday, following Monday's gains.
In 'What's Ahead on Wall Street' for Tuesday April 19, the day is packed with earnings reports.
Jim Cramer awaits quarterly results from Johnson & Johnson, released before the bell on Tuesday.
The easiest way to get in trouble in the market is not to embrace the obvious.
A few charts point out why it's necessary to have a bullish stance despite how far stocks have moved already.